MedTrace Logo

Dexmedetomidine Nasal Spray and Pediatric Bronchoscopy

NCT06755996 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-01-27

No results posted yet for this study

Summary

To observe the sedative effect of using dexmedetomidine nasal spray combined with remimazolam for pediatric bronchoscopy diagnosis and treatment, provide a safer and more comfortable anesthesia plan for pediatric bronchoscopy diagnosis and treatment

Conditions

  • Fiberoptic Bronchoscopy

Interventions

DRUG

Dexmedetomidine injection

Dexmedetomidine injection 3μg/kg

DRUG

Remimazolam

remimazolam 0.5mg / kg

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • pu zhou, Dr. · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-07
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06755996 on ClinicalTrials.gov